The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Chemical constituents of marijuana: The complex mixture of natural cannabinoids
Abstract
The cannabis plant (Cannabis sativa L.) and products thereof (such as marijuana, hashish and hash oil) have a long history of use both as a medicinal agent and intoxicant. Over the last few years there have been an active debate regarding the medicinal aspects of cannabis. Currently cannabis products are classified as Schedule I drugs under the Drug Enforcement Administration (DEA) Controlled Substances act, which means that the drug is only available for human use as an investigational drug. In addition to the social aspects of the use of the drug and its abuse potential, the issue of approving it as a medicine is further complicated by the complexity of the chemical make up of the plant. This manuscript discusses the chemical constituents of the plant with particular emphasis on the cannabinoids as the class of compounds responsible for the drug's psychological properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), dominate the current understanding of Cannabis bioactivity, other specialized metabolites—including alkaloids, flavonoids, and stilbenes—also contribute to its pharmacological profile but remain less studied [2,9,10].”
In the citing paper
“More than 90 different cannabinoids have been reported in the literature, although some of these are breakdown products (ElSohly and Slade, 2005; Brenneisen, 2007; Radwan et al., 2009; Fischedick et al., 2010) and they are generally classified into 10 subclasses (Brenneisen, 2007).”
From Cannabis sativa: The Plant of the Thousand and One Molecules (2016) · cites this paper as ElSohly and Slade, 2005
Citations
Cites
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Constituents of Cannabis sativa L. XVII. A review of the natural constituents
Turner, C. E., Elsohly, M. A., & Boeren, E. G. (1980) · Journal of Natural Products · doi:10.1021/np50008a001 · Cited by 599
Self-citationStructure-activity relationships in cannabinoids.
Razdan, R. K. (1986) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06863-2 · Cited by 373
Gaoni, Y., & Mechoulam, R. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00730a036 · Cited by 364
Chemical Basis of Hashish Activity
Mechoulam, R., Shani, A., Edery, H., & Grunfeld, Y. (1970) · Science · doi:10.1126/science.169.3945.611 · Cited by 331
Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp. I
ADAMS, R. L. P., Hunt, M., & Clark, J. H. (1940) · Journal of the American Chemical Society · doi:10.1021/ja01858a058 · Cited by 302
Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential
(2003) · Choice Reviews Online · doi:10.5860/choice.40-3432 · Cited by 293
The absolute configuration of δ1-tetrahydrocannabinol, the major active constituent of hashish.
Mechoulam, R., & Gaoni, Y. (1967) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)90646-4 · Cited by 234
Mechoulam, R., & Gaoni, Y. (1965) · Tetrahedron · doi:10.1016/0040-4020(65)80064-3 · Cited by 197
The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects
(1984) · Elsevier eBooks · doi:10.1016/b978-0-12-044620-9.x5001-5 · Cited by 189
Flagged first, then by citations
1 of the 71 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Gaoni, 1964, Structure and synthesis of cannabigerol, a new hashish constituent, Proceedings of the Chemical Society, 82
- Morita, 1984, Analysis of hashish oil by gas chromatography/mass spectrometry, Kagaku Keisatsu Kenkyujo Hokoku. Hokagaku-Hen, 37, 137
- Pate, D. 1999. Anandamide structure-activity relationships and mechanisms of action on intraocular pressure in the normotensive rabbit model. Ph.D. thesis, University of Kuopio, Kuopio, Finland.
Cited by
Sorted by citations
Cannabis sativa: The Plant of the Thousand and One Molecules
Andre, C. M., Hausman, J.-F., & Guerriero, G. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00019 · Cited by 1,544
“More than 90 different cannabinoids have been reported in the literature, although some of these are breakdown products (ElSohly and Slade, 2005; Brenneisen, 2007; Radwan et al., 2009; Fischedick et al., 2010) and they are generally classified into 10 subclasses (Brenneisen, 2007).”
BackgroundDe Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01166.x · Cited by 946
Phytocannabinoids: a unified critical inventory
Hanuš, L. O., Meyer, S. M., Muñoz, E., Taglialatela-Scafati, O., & Appendino, G. (2016) · Natural Product Reports · doi:10.1039/c6np00074f · Cited by 844
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019) · Antioxidants · doi:10.3390/antiox9010021 · Cited by 889
Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 763
Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study
Appendino, G., Gibbons, S., Giana, A., Pagani, A., Grassi, G., Stavri, M., Smith, E., & Rahman, M. M. (2008) · Journal of Natural Products · doi:10.1021/np8002673 · Cited by 661
Multiple Functions of Endocannabinoid Signaling in the Brain
Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630
The draft genome and transcriptome of Cannabis sativa.
van Bakel, H., Stout, J. M., Cote, A. G., Tallon, C. M., Sharpe, A. G., Hughes, T. R., & Page, J. E. (2011) · Genome Biology · doi:10.1186/gb-2011-12-10-r102 · Cited by 575
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.
Burstein, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.059 · Cited by 573
Cannabis use and cannabis use disorder
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00247-4 · Cited by 552
Phytochemistry of Cannabis sativa L.
ElSohly, M. A., Radwan, M. M., Gul, W., Chandra, S., & Galal, A. M. (2017) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-319-45541-9_1 · Cited by 584
Self-citationMehmedic, Z., Chandra, S., Slade, D., Denham, H., Foster, S., Patel, A. S., Ross, S. A., Khan, I. A., & ElSohly, M. A. (2010) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2010.01441.x · Cited by 475
Self-citationAizpurua‐Olaizola, O., Soydaner, U., Öztürk, E., Schibano, D., Simsir, Y., Navarro, P., Etxebarría, N., & Usobiaga, A. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00949 · Cited by 487
Molecular Targets of the Phytocannabinoids: A Complex Picture
Morales, P., Hurst, D. P., & Reggio, P. H. (2017) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-319-45541-9_4 · Cited by 499
Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization.
Small, E. (2015) · The Botanical Review · doi:10.1007/s12229-015-9157-3 · Cited by 461
Secondary metabolism in cannabis
Flores-Sanchez, I. J., & Verpoorte, R. (2008) · Phytochemistry Reviews · doi:10.1007/s11101-008-9094-4 · Cited by 400
Deiana, S., Watanabe, A., Yamasaki, Y., Amada, N., Arthur, M., Fleming, S., Woodcock, H., Dorward, P. K., Pigliacampo, B., Close, S., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2415-0 · Cited by 422
Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis
Radwan, M. M., Chandra, S., Gul, S., & ElSohly, M. A. (2021) · Molecules · doi:10.3390/molecules26092774 · Cited by 397
Self-citationPhytocannabinoids: Origins and Biosynthesis
Gülck, T., & Møller, B. L. (2020) · Trends in Plant Science · doi:10.1016/j.tplants.2020.05.005 · Cited by 428
Pellati, F., Borgonetti, V., Brighenti, V., Biagi, M., Benvenuti, S., & Corsi, L. (2018) · BioMed Research International · doi:10.1155/2018/1691428 · Cited by 430
Mechanisms contributing to prefrontal cortex maturation during adolescence
Caballero, A., Granberg, R., & Tseng, K. Y. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.013 · Cited by 357
Stout, S. M., & Cimino, N. M. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.849268 · Cited by 350
Jin, D., Dai, K., Xie, Z., & Chen, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-60172-6 · Cited by 348
Fischedick, J. T., Hazekamp, A., Erkelens, T., Choi, Y. H., & Verpoorte, R. (2010) · Phytochemistry · doi:10.1016/j.phytochem.2010.10.001 · Cited by 325
Phytocannabinoids as novel therapeutic agents in {CNS} disorders.
Hill, A. J., Williams, C. M., Whalley, B. J., & Stephens, G. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.002 · Cited by 312
Crane, N. A., Schuster, R. M., Fusar‐Poli, P., & González, R. (2012) · Neuropsychology Review · doi:10.1007/s11065-012-9222-1 · Cited by 330
Spicing things up: synthetic cannabinoids
Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3188-4 · Cited by 314
Nissen, L., Zatta, A., Stefanini, I., Grandi, S., Sgorbati, B., Biavati, B., & Monti, A. (2009) · Fitoterapia · doi:10.1016/j.fitote.2009.11.010 · Cited by 296
Cannabis and psychosis/schizophrenia: human studies
D’Souza, D. C., Sewell, R. A., & Ranganathan, M. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0024-2 · Cited by 306
Brown, J. D., & Winterstein, A. G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070989 · Cited by 295
A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis
Berman, P., Futoran, K., Lewitus, G. M., Mukha, D., Benami, M., Shlomi, T., & Meiri, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-32651-4 · Cited by 301
Cannabinoids and Cytochrome P450 Interactions
Zendulka, O., Dovrtělová, G., Nosková, K., Turjap, M., Šulcová, A., Hanuš, L., & Juřica, J. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666151210142051 · Cited by 308
Gagne, S. J., Stout, J. M., Liu, E., Boubakir, Z., Clark, S. M., & Page, J. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200330109 · Cited by 287
The antimicrobial potential of cannabidiol
Blaskovich, M. A. T., Kavanagh, A. M., Elliott, A. G., Zhang, B., Ramu, S., Amado, M., Lowe, G. J., Hinton, A. O., Pham, D. M. T., Zuegg, J., et al. (2021) · Communications Biology · doi:10.1038/s42003-020-01530-y · Cited by 323
Backer, B. D., Debrus, B., Lebrun, P., Theunis, L., Dubois, N., Decock, L., Verstraete, A., Hubert, P., & Charlier, C. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.11.004 · Cited by 285
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation
Galve‐Roperh, I., Chiurchiù, V., Díaz-Alonso, J., Bari, M., Guzmán, M., & Maccarrone, M. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.05.004 · Cited by 287
Rosenberg, E. C., Tsien, R. W., Whalley, B. J., & Devinsky, O. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0375-5 · Cited by 292
Solmi, M., Toffol, M. D., Kim, J. Y., Choi, M., Stubbs, B., Thompson, T., Firth, J., Miola, A., Croatto, G., Baggio, F., et al. (2023) · BMJ · doi:10.1136/bmj-2022-072348 · Cited by 322
The case for medical marijuana in epilepsy
Maa, E. H., & Figi, P. (2014) · Epilepsia · doi:10.1111/epi.12610 · Cited by 285
Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Bruni, N., Pepa, C. D., Oliaro‐Bosso, S., Pessione, E., Gastaldi, D., & Dosio, F. (2018) · Molecules · doi:10.3390/molecules23102478 · Cited by 317
El‐Alfy, A. T., Ivey, K., Robinson, K., Ahmed, S. A., Radwan, M. M., Slade, D., Khan, I. A., ElSohly, M. A., & Ross, S. A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.03.004 · Cited by 278
Self-citationBrighenti, V., Pellati, F., Steinbach, M., Maran, D., & Benvenuti, S. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.05.049 · Cited by 272
Baron, E. P. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13345 · Cited by 268
Molecular Pharmacology of Phytocannabinoids
Turner, S. E., Williams, C. M., Iversen, L. L., & Whalley, B. J. (2017) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-319-45541-9_3 · Cited by 264
Cascio, M. G., Gauson, L., Stevenson, L. A., Ross, R., & Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00515.x · Cited by 242
Evidence for the Risks and Consequences of Adolescent Cannabis Exposure
Levine, A., Clemenza, K., Rynn, M., & Lieberman, J. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.12.014 · Cited by 239
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Silvestro, S., Mammana, S., Cavalli, E., Bramanti, P., & Mazzon, E. (2019) · Molecules · doi:10.3390/molecules24081459 · Cited by 249
Laverty, K. U., Stout, J. M., Sullivan, M. J., Shah, H., Gill, N., Holbrook, L. A., Deikus, G. Y., Sebra, R., Hughes, T. R., Page, J. E., et al. (2018) · Genome Research · doi:10.1101/gr.242594.118 · Cited by 246
Cannabis with high cannabidiol content is associated with fewer psychotic experiences
Schubart, C. D., Sommer, I. E., van Gastel, W. A., Goetgebuer, R., Kahn, R. S., & Boks, M. P. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.04.017 · Cited by 238
Ferber, S. G., Namdar, D., Hen-Shoval, D., Eger, G., Koltai, H., Shoval, G., Shbiro, L., & Weller, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190903103923 · Cited by 239
Yamaori, S., Ebisawa, J., Okushima, Y., Yamamoto, I., & Watanabe, K. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.02.017 · Cited by 222
Cannabis potency and contamination: a review of the literature
McLaren, J., Swift, W., Dillon, P., & ALLSOP, S. J. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02230.x · Cited by 212
Cannabis use during adolescent development: Susceptibility to psychiatric illness
Chadwick, B., Miller, M. L., & Hurd, Y. L. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00129 · Cited by 210
Cannabinoids: Occurrence and Medicinal Chemistry
Appendino, G., Chianese, G., & Taglialatela‐Scafati, O. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794940888 · Cited by 209
Neuropathology of substance use disorders
Cadet, J. L., Bisagno, V., & Milroy, C. M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1221-7 · Cited by 217
Baron, E. P. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12570 · Cited by 219
Stout, J. M., Boubakir, Z., Ambrose, S. J., Purves, R. W., & Page, J. E. (2012) · The Plant Journal · doi:10.1111/j.1365-313x.2012.04949.x · Cited by 202
Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol
Ross, H., Napier, I. A., & Connor, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707104200 · Cited by 203
Cannabidiol in Humans—The Quest for Therapeutic Targets
Zhornitsky, S., & Potvin, S. (2012) · Pharmaceuticals · doi:10.3390/ph5050529 · Cited by 205
New Methods for the Comprehensive Analysis of Bioactive Compounds in Cannabis sativa L. (hemp)
Pellati, F., Brighenti, V., Sperlea, J., Marchetti, L., Bertelli, D., & Benvenuti, S. (2018) · Molecules · doi:10.3390/molecules23102639 · Cited by 209
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep
Piper, B. J., DeKeuster, R. M., Beals, M. L., Cobb, C. M., Burchman, C. A., Perkinson, L., Lynn, S. T., Nichols, S. D., & Abess, A. T. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117699616 · Cited by 197
Hill, T. D. M., Cascio, M. G., Romano, B., Duncan, M., Pertwee, R. G., Williams, C. M., Whalley, B. J., & Hill, A. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12321 · Cited by 189
Happyana, N., Agnolet, S., Muntendam, R., Van Dam, A., Schneider, B., & Kayser, O. (2013) · Phytochemistry · doi:10.1016/j.phytochem.2012.11.001 · Cited by 187
Biologically Active Cannabinoids from High-Potency Cannabis sativa
Radwan, M. M., ElSohly, M. A., Slade, D., Ahmed, S. A., Khan, I. A., & Ross, S. A. (2009) · Journal of Natural Products · doi:10.1021/np900067k · Cited by 185
Self-citationHartsel, J. A., Eades, J., Hickory, B., & Makriyannis, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802147-7.00053-x · Cited by 204
Kusari, P., Kusari, S., Spiteller, M., & Kayser, O. (2012) · Fungal Diversity · doi:10.1007/s13225-012-0216-3 · Cited by 181
Cass, D. K., Flores-Barrera, E., Thomases, D. R., Vital, W. F., Caballero, A. C., & Tseng, K. Y. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.14 · Cited by 182
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
Morales, P., Reggio, P. H., & Jagerovic, N. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00422 · Cited by 188
The endocannabinoid system as a target for the treatment of neurodegenerative disease
Scotter, E. L., Abood, M. E., & Glass, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00735.x · Cited by 188
Fibre hemp inflorescences: From crop-residues to essential oil production
Bertoli, A., Tozzi, S., Pistelli, L., & Angelini, L. G. (2010) · Industrial Crops and Products · doi:10.1016/j.indcrop.2010.05.012 · Cited by 173
Cannabidivarin is anticonvulsant in mouse and rat
Hill, A. G., Mercier, M., Hill, T., Glyn, S., Jones, N., Yamasaki, Y., Futamura, T., Duncan, M., Stott, C., Stephens, G. J., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02207.x · Cited by 179
Aizpurua‐Olaizola, O., Omar, J., Navarro, P., Olivares, M., Etxebarría, N., & Usobiaga, A. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8177-x · Cited by 165
Hurd, Y. L., Yoon, M. J., Manini, A. F., Hernandez, S. H., Olmedo, R., Östman, M., & Jutras‐Aswad, D. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0373-7 · Cited by 171
Supercritical carbon dioxide extraction of cannabinoids from Cannabis sativa L
Rovetto, L. J., & Aieta, N. V. (2017) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2017.03.014 · Cited by 166
Yamaori, S., Kushihara, M., Yamamoto, I., & Watanabe, K. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.028 · Cited by 165
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
Stella, B., Baratta, F., Pepa, C. D., Arpicco, S., Gastaldi, D., & Dosio, F. (2021) · Drugs · doi:10.1007/s40265-021-01579-x · Cited by 181
Genomic and Chemical Diversity in Cannabis
Lynch, R. C., Vergara, D., Tittes, S. B., White, K., Schwartz, C. J., Gibbs, M. J., Ruthenburg, T. C., deCesare, K., Land, D. P., & Kane, N. C. (2016) · Critical Reviews in Plant Sciences · doi:10.1080/07352689.2016.1265363 · Cited by 167
Cannabinoid receptors: nomenclature and pharmacological principles
Console‐Bram, L., Marcu, J. P., & Abood, M. E. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.009 · Cited by 169
Li, H., Liu, Y., Tian, D., Tian, L., Ju, X., Qi, L., Wang, Y., & Liang, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112163 · Cited by 167
Citti, C., Linciano, P., Panseri, S., Vezzalini, F., Forni, F., Vandelli, M. A., & Cannazza, G. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00120 · Cited by 155
Nitrogen supply affects cannabinoid and terpenoid profile in medical cannabis (Cannabis sativa L.)
Saloner, A., & Bernstein, N. (2021) · Industrial Crops and Products · doi:10.1016/j.indcrop.2021.113516 · Cited by 152
Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6
Yamaori, S., Okamoto, Y., Yamamoto, I., & Watanabe, K. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.041384 · Cited by 151
Constituents of Cannabis Sativa
Rock, E. M., & Parker, L. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_1 · Cited by 171
The Polypharmacological Effects of Cannabidiol
Castillo-Arellano, J. I., Canseco-Alba, A., Cutler, S. J., & León, F. (2023) · Molecules · doi:10.3390/molecules28073271 · Cited by 172
Scott, K. A., Dalgleish, A. G., & Liu, W. M. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0402 · Cited by 155
Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products
Anderson, G. D., & Chan, L. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0400-9 · Cited by 141
Prenatal cannabis exposure - The “first hit” to the endocannabinoid system
Richardson, K. A., Hester, A. K., & McLemore, G. L. (2016) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2016.08.003 · Cited by 145
Ren, M., Tang, Z., Wu, X., Spengler, R. N., Jiang, H., Yang, Y., & Boivin, N. L. (2019) · Science Advances · doi:10.1126/sciadv.aaw1391 · Cited by 143
Emerging diseases of Cannabis sativa and sustainable management
Punja, Z. K. (2021) · Pest Management Science · doi:10.1002/ps.6307 · Cited by 135
Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance
González, R. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9036-8 · Cited by 140
Non-cannabinoid constituents from a high potency Cannabis sativa variety
Radwan, M. M., ElSohly, M. A., Slade, D., Ahmed, S. A., Wilson, L., El‐Alfy, A. T., Khan, I. A., & Ross, S. A. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2008.07.010 · Cited by 135
Self-citationYamaori, S., Koeda, K., Kushihara, M., Hada, Y., Yamamoto, I., & Watanabe, K. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-107 · Cited by 131
Impact of Cannabis Use on the Development of Psychotic Disorders
Wilkinson, S. T., Radhakrishnan, R., & D’Souza, D. C. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0018-7 · Cited by 139
Chemical Profiling of Medical Cannabis Extracts
Lewis, M. M., Yang, Y., Wasilewski, E., Clarke, H. A., & Kotra, L. P. (2017) · ACS Omega · doi:10.1021/acsomega.7b00996 · Cited by 132
A review of methods for the chemical characterization of cannabis natural products
Leghissa, A., Hildenbrand, Z. L., & Schug, K. A. (2017) · Journal of Separation Science · doi:10.1002/jssc.201701003 · Cited by 146
Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa
Radwan, M. M., ElSohly, M. A., El‐Alfy, A. T., Ahmed, S. A., Slade, D., Husni, A. S., Manly, S. P., Wilson, L., Seale, S., Cutler, S. J., et al. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00065 · Cited by 133
Self-citationCannabis Glandular Trichomes: A Cellular Metabolite Factory
Tanney, C. A. S., Backer, R. G. M., Geitmann, A., & Smith, D. L. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.721986 · Cited by 129
Safety and Toxicology of Cannabinoids
Sachs, J., McGlade, E., & Yurgelun-Todd, D. A. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0380-8 · Cited by 134
Verkouteren, J. R., & Staymates, J. L. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.08.005 · Cited by 127
Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review
Balachandran, P., ElSohly, M. A., & Hill, K. P. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06504-8 · Cited by 126
Self-citation
Metadata
- Authors
- ElSohly, M. A., & Slade, D.
- Affiliations
- University of Mississippi (US)
- Corresponding author
- ElSohly, Mahmoud A.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 78
- Issue
- 5
- Pages
- 539-548
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2114062911
- Cited by
- 1,094
- References
- 71
- Citations by year
- 2026: 33 · 2025: 60 · 2024: 69 · 2023: 104 · 2022: 82 · 2021: 116 · 2020: 90 · 2019: 82 · 2018: 70 · 2017: 55 · 2016: 56 · 2015: 52 · 2014: 35 · 2013: 28 · 2012: 35
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Life Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Life Sciences › Agricultural and Biological Sciences › Food Science › Hops Chemistry and Applications
- Keywords
- cannabinoids, Cannabis sativa, cannabis, hashish, chemical constituents, medical cannabis, Schedule I drug classification, psychoactive effects
- MeSH terms
- Cannabinoids, Cannabis, Complex Mixtures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review